High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia

Show full item record



Permalink

http://hdl.handle.net/10138/162089

Citation

Karimi , M , Nilsson , C , Dimitriou , M , Jansson , M , Matsson , H , Unneberg , P , Lehmann , S , Kere , J & Hellstrom-Lindberg , E 2015 , ' High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia ' Haematologica , vol. 100 , no. 6 , pp. E223-E225 . DOI: 10.3324/haematol.2014.118034

Title: High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Author: Karimi, Mohsen; Nilsson, Christer; Dimitriou, Marios; Jansson, Monika; Matsson, Hans; Unneberg, Per; Lehmann, Soren; Kere, Juha; Hellstrom-Lindberg, Eva
Contributor: University of Helsinki, Research Programmes Unit
Date: 2015-06
Language: eng
Number of pages: 3
Belongs to series: Haematologica
ISSN: 0390-6078
URI: http://hdl.handle.net/10138/162089
Subject: myelodysplastic syndromes
acute myeloid leukemia
secondary
therapy-related
high-throughput mutational screening
ADULTS RECOMMENDATIONS
EUROPEAN LEUKEMIANET
DIAGNOSIS
3121 Internal medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
100e223.pdf 555.8Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record